What is Edgewise Therapeutics, Inc.'s net investment in lease?

Edgewise Therapeutics, Inc. (EWTX) reported net investment in lease of $1.33M in Q1 2026.

How has Edgewise Therapeutics, Inc.'s net investment in lease changed year-over-year?

Edgewise Therapeutics, Inc.'s net investment in lease decreased by 12.7% year-over-year, from $1.53M to $1.33M.

What is the long-term trend for Edgewise Therapeutics, Inc.'s net investment in lease?

Over 3 years (2022 to 2025), Edgewise Therapeutics, Inc.'s net investment in lease has grown at a 1.7% compound annual growth rate (CAGR), from $1.32M to $1.39M.

Edgewise Therapeutics, Inc. EWTX Net Investment in Lease

Net Investment in Lease at other companies

CytokineticsCYTK

——

PTC TherapeuticsPTCT

——

Catalyst PharmaceuticalCPRX

——

Dyne Therapeutics, Inc.DYN

——

Viking TherapeuticsVKTX

——

Scholar RockSRRK

——

Other financials

Income statement

See full

Operating income-$54.1M-17.7%

Net income-$49.0M-20.1%

EPS (diluted)-$0.46-7.0%

Balance sheet

See full

Cash & equivalents$33.2M-33.5%

Total debt$3.8M-16.8%

Total equity$493.2M+14.8%

Total assets$518.5M+14.1%

Cash flow

See full

Operating cash flow-$42.5M-12.4%

CapEx$260.0K+491%

Free cash flow-$42.8M-12.9%

Valuation

See full

Market cap$4.18B+61.3%

Returns & leverage

See full

Return on equity-38.1%+13.4pp

Debt / equity0×0.0×

Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s net investment in lease?: Edgewise Therapeutics, Inc. (EWTX) reported net investment in lease of $1.33M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s net investment in lease changed year-over-year?: Edgewise Therapeutics, Inc.'s net investment in lease decreased by 12.7% year-over-year, from $1.53M to $1.33M.
What is the long-term trend for Edgewise Therapeutics, Inc.'s net investment in lease?: Over 3 years (2022 to 2025), Edgewise Therapeutics, Inc.'s net investment in lease has grown at a 1.7% compound annual growth rate (CAGR), from $1.32M to $1.39M.